Emiliano Calvo, M.D., Ph.D., is the Director of START Madrid Group in Madrid (Early Phase Clinical Drug Development in Oncology, international program) and the Director of Clinical Research at the START Madrid-Centro Integral Oncológico Clara Campal hospital, in Madrid, Spain, from its launch in 2008. He is also the President of the Investigational Therapeutics in Oncological Sciences Foundation (Intheos). In addition, he is an Associate Professor at University CEU San Pablo in Madrid, Spain, Faculty member (from 2012) and ESMO Director at the International Workshop in Methods in Clinical Cancer Research, in Flims, Switzerland (2017-2019), and Track Leader (2015-6) and Committee member (from 2014) for the Scientific Program Committee on the Developmental Therapeutics - Clinical Pharmacology & Experimental Track of the Annual Meetings of the American Society of Clinical Oncology (ASCO), as well as honorary member of the Cancer Education Committee of ASCO (2015-2016). During 2006-2011 and from 2015 on, he is a Faculty Member of the ESMO (European Society of Medical Oncology) Educational Committee, for the special expertise group “Principles of Clinical Trials and Systemic Therapy”, and, also, from 2014 Faculty member of the ESMO Educational Committee for the special expertise group “non-prostate genitourinary tumors”. In addition, he has been a member of the Scientific Committee of the ESMO-ECCO anual meeting (2008, 2009 and 2011 –Developmental Therapeutics track-) and, from 2015, at the annual EORTC-NCI-AACR International Conference on Molercular Targets and Cancer Therapeutics
He earned his M.D. in 1993 at the Universidad Autónoma de Madrid in Madrid, Spain and his Ph.D. in 2003 at the Universidad de Navarra in Pamplona, Spain, with highest commendation. He trained in Medical Oncology at the Clínica Universitaria de Navarra in Pamplona, Spain and completed his Advanced Fellowship in Drug Development at the Cancer Therapy & Research Center’s Institute for Drug Development in San Antonio, Texas, from 2003 to 2005, where he was a Senior Fellow and Clinical Investigator.
While working in the Medical Oncology Department at the Hospital Vall d'Hebron in Barcelona, Spain, from 2005 to 2008, Dr. Calvo was Co-Director and Senior Researcher of the Phase I Unit and director of the Genitorurinary Tumors Program.
Dr. Calvo has co-authored approximately one hundred publications, especially regarding clinical development of new drugs in different tumor types and in kidney cancer. These publications include scientific articles, chapters in oncology books and presentations at different major conferences and meetings. During these last 12 years of almost full dedication to Clinical Drug development in Oncology, he has participated in around two hundred international studies, as a clinical investigator, specially in Early Clinical Drug Development and in kidney cancer. He serves as an ad-hoc reviewer of various oncology journals, recently named board editor for European Journal of Cancer, and is a panel expert advisor at multiple Advisory Boards of anticancer drug development and kidney cancer therapeutics.